Skip to content

Ranbaxy announces new co-packaged triple ART combinations

Some groups get more benefit from anti-HIV drugs than others

Poor immmunologic response to HAART should be cause for concern in viral load responders

Selective taking of anti-HIV drugs associated with higher rate of AIDS and death

Directly observed therapy shown to be of value for some patients

Manchester’s oldest HIV self-help group faces closure in September

Sexual transmission of HCV found in Swiss HIV-positive gay men

Response to HAART improves due to better drugs and more expertise in their use

Low level and intermittent HIV replication during very early infection